Curriculum Vitae

MYTHILI GURRAM, M.D., FACAAI

PERSONAL INFORMATION

Work Status:

Private Practice Since 1992
EVANSVILLE, Indiana

January 2002 to Date @ Current Location
Adult & Pediatric Allergy and Clinical Immunology
3700 Bellemeade Avenue, Suite 122
Evansville, IN 47714
Tel: 812-473-7225

October 1992 to January 2002
Welborn Clinic
421 Chestnut Street
Evansville, IN 47713

Board Certifications:

September 1989
American Board of Internal Medicine

October 1993
American Board Allergy and Immunology

Recertified in 2003
Indiana State # 01040824

Licensure:

Education:

October 1990 to September 1992
Fellowship in Allergy & Immunology
Northshore University Hospital,
Nassau County Medical Center

Cornell Medical College Program
350 Community Drive
Manhasset, NY 11213

July 1989 to September 1990
Fellowship in Hematology
University of Illinois
840 S. Wood Street
Chicago, IL 60612

July 1986 to June 1989
Residency in Internal Medicine
Grant Hospital of Chicago
Chicago, IL 60014

Medical College:

July 1972 to September 1979
Guntur Medical College
Guntur, A.P, India

Professional Memberships:

American College of Allergy & Immunology
American Academy of Allergy &. Immunology
Indiana State Medical Association
Vanderburg County Medical Society

Abstracts & Presentations:

Increased spontaneous secretion of Interlukin -6 and Tumor Necrosis Factor Alpha by peripheral blood Lymphocytes of HIV infected children. Mythili Gurram, M.D; Narendra Chirmule, Ph D; Xue-Ping Wang, Ph D; Nagarjuna Ponugati, M.D; Savita Pahwa, M.D.
Journal of Pediatric lnfectious Diseases.

Augmented Interlukin -6 secretion in collagen stimulated peripheral blood mononuclear cells from patients with Systemic Sclerosis. Mythili Gurram, M.D; Savita Pahwa, M.D; Marianne Frieri, M.D

Oral presentation at 48th annual meeting of American Academy of Allergy & Immunology
Orlando, Florida in March 1992.

Clinical & Laboratory Research:

lnterlukin -6 in patients with Common Variable Immune Deficiency

Polycythemia vera and its clinical association with various autoimmune diseases.

Randomized trail of Alpha Interferon as remission maintenance treatment in patients with Multiple Myeloma.

Case report of a patient with Myelofibrosis with subsequent development of
Chronic Lymphocytic Leukemia.